Profile
GTBP VRTX REGN SGEN ALNY ARGX
Company Name GT Biopharma, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $8.59M $116.96B $58.10B $43.15B $41.50B $33.28B
Employees 0.00K 6.10K 15.16K 3.26K 2.23K 1.60K
CEO Mr. Alan Louis Urban CPA Dr. Reshma Kewalramani FASN, M.D. Leonard S. Schleifer David R. Epstein Yvonne L. Greenstreet Timothy Van Hauwermeiren EMBA,
Ratings
GTBP VRTX REGN SGEN ALNY ARGX
Quant Rating Score 1 2 4 3 1 2
Quant Rating Strong Sell Sell Buy Neutral Strong Sell Sell
Trading
GTBP VRTX REGN SGEN ALNY ARGX
Last Close $2.78 $459.62 $547.36 $228.74 $331.91 $543.48
High 52 $3.8 $516.74 $1201.76 $228.74 $331.91 $671.75
Low 52 $1.75 $396.64 $482.92 $228.74 $224.58 $435.29
Price vs. 52 Week High -26.84 % -11.05 % -54.45 % 0 % 0 % -19.09 %
Price vs. 52 Week Low 58.86 % 15.88 % 13.34 % 0 % 47.79 % 24.85 %
Total Return
GTBP VRTX REGN SGEN ALNY ARGX
1 Month Return 3.35 % 3.09 % 12.88 % 0 % 8.71 % -5.24 %
3 Month Return 18.3 % -3.16 % -4.54 % 0 % 40.79 % -2.1 %
6 Month Return -7.33 % 12.9 % -23.78 % 0 % 41.67 % -12.52 %
9 Month Return 37.62 % 0.95 % -45.96 % 0 % 23.85 % 2.55 %
YTD Return -8.85 % 14.13 % -23.16 % 0 % 41.05 % -11.63 %
1 Year Return 1.09 % -2.27 % -46.55 % 0 % 33.47 % 24.85 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
GTBP VRTX REGN SGEN ALNY ARGX
Dividend Yield Percentage (TTM) - - 0.32 % - - -
Dividend Paid and Capex Coverage Ration (TTM) - -3.53 % 3.85 % -5.87 % -1.49 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Profitability
GTBP VRTX REGN SGEN ALNY ARGX
Gross Profit Margin TTM - 86.03 % 84.94 % 79.1 % 86.01 % 46.33 %
Return on Assets TTM -439.13 % -4.32 % 11.98 % -16.61 % -6.4 % 13.45 %
Return on Equity TTM -786.66 % -6.25 % 14.77 % -20.8 % -509.33 % 16.83 %
Return on Capital Employed TTM 1347.45 % -3.89 % 11.35 % -21.46 % -3.68 % -0.5 %
Net Income Per EBT TTM 100 % 329.41 % 90.27 % 101.33 % 75.89 % 25990.14 %
EBT Per Ebit TTM 88.39 % 40.44 % 129.3 % 98.26 % 308.03 % -11.64 %
EBIT Per Revenue TTM - -6.69 % 27.37 % -31.24 % -4.91 % -1.24 %
Cash Flow To Debt Ratio TTM - -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Receivables Turnover TTM - 6.15 2.53 3.91 5.62 2.36
Payables Turnover TTM - 3.49 3.01 1.97 3.37 2.39
Inventory Turnover TTM - 1.14 0.66 0.96 5.01 2.93
Fixed Asset Turnover TTM - 421.34 % 300.07 % 665.41 % 337.41 % 5106.8 %
Asset Turnover TTM - 48.51 % 37.52 % 53.41 % 55.72 % 35.83 %
Operating Cash Flow Per Share TTM -4.67 -3.82 37.05 -2.46 -0.35 -1.07
Free Cash Flow Per Share TTM -4.67 -4.9 28.3 -2.88 -0.58 -1.09
Cash Per Share TTM 100.85 % 2413.86 % 7825.12 % 939.52 % 2024.29 % 4688.94 %
Operating Cash Flow Sales Ratio TTM - -8.83 % 28.06 % -23.12 % -1.92 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 128.33 % 76.4 % 117.04 % 167.11 % 102.26 %
Cash Flow Coverage Ratios TTM - -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Price To Free Cash Flows Ratio TTM -0.78 -92.97 19.24 -81.26 -550.45 -434.25
Price To Operating Cash Flows Ratio TTM -0.71 -119.36 14.77 -93.1 -914.84 -515.98
Price Cash Flow Ratio TTM -0.71 -119.36 14.77 -93.1 -914.84 -515.98
Income Statement (TTM)
GTBP VRTX REGN SGEN ALNY ARGX
Revenue $0B $11.02B $14.2B $1.96B $2.25B $2.19B
Gross Profit $0B $9.49B $12.23B $1.55B $1.92B $1.96B
Gross Profit Ratio 0% 86.11% 86.13% 79.1% 85.62% 89.62%
EBITDA $-0.01B $0.49B $5.32B $-0.62B $-0.18B $0.11B
Net Income $-0.01B $-0.54B $4.41B $-0.61B $-0.28B $0.83B
EPS Diluted -6.94 -2.08 38.34 -3.3 -2.16 12.78
Balance Sheet (MRQ)
GTBP VRTX REGN SGEN ALNY ARGX
Long Term Debt $0B $1.66B $1.98B $0.04B $0B $0.03B
Total Liabilities $0.01B $6.12B $8.41B $0.87B $4.17B $0.7B
Total Equity $-0B $16.41B $29.35B $2.8B $0.07B $5.5B
Total Investments $0B $6.65B $15.42B $1.42B $1.73B $1.93B
Total Debt $0B $1.75B $2.7B $0.04B $1.3B $0.04B
Total Assets $0B $22.53B $37.76B $3.67B $4.3B $6.2B
Cash Flow Statement (TTM)
GTBP VRTX REGN SGEN ALNY ARGX
Net Income $-0.01B $-0.54B $4.41B $-0.61B $-0.28B $-0.02B
Inventory $0B $-0.52B $-0.62B $-0.23B $0.01B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.49B $4.42B $-0.45B $-0.01B $-0.08B
Capital Expenditure $0B $-0.3B $-0.76B $-0.08B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 42.85
AARD Aardvark Therapeutics, Inc. Common Stock 13.92
ABCL AbCellera Biologics Inc. 3.81
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.8
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.16
ABPWW 0.0222
ABSI Absci Corporation 2.76
ABUS Arbutus Biopharma Corporation 3.24
ABVC ABVC BioPharma, Inc. 3.14
ABVX Abivax SA American Depositary Shares 7.9
ACAD ACADIA Pharmaceuticals Inc. 20.95
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.607
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.23
ACIU AC Immune SA 2.07
ETFs With Exposure to GTBP
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 308.03
VXF Vanguard Extended Market Index Fund 0.00002 197.5
IWC iShares Micro-Cap ETF 0.01 133.09
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 104.8
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 104.79
VTSAX Vanguard Total Stock Market Index Fund 0 150.01
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00002 149.82
VITSX Vanguard Total Stock Market Index Fund 0 150.04
DFSU Dimensional US Sustainability Core 1 ETF 0.0000039452 39.96
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00002 149.83
VEMPX Vanguard Extended Market Index InstlPlus 0.00002 369.73
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 281.45
Unlock